Physician

James A Coman, M.D.

According to 2025 Medicare claims, James Coman, M.D. (NPI: 1417927815) practices cardiac electrophysiology in the Albany, GA market, with the plurality of this provider's patient population coming from Dougherty, GA. This provider's primary affiliated billing organization is PHOEBE PHYSICIAN GROUP INC (NPI: 1487899464; TIN: 263792403) and primary practice location at 31701-1943. Coman is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Coman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 731 traditional Medicare patients, billed 3,884 HCPCS/CPT codes, and received $260,720 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,215 prescription claims across 336 beneficiaries totaling $539,094 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 14 records totaling $315. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $530,547 to $260,720. In contrast, Part D prescription costs have moved sharply higher in recent years, from $207,940 to $539,094. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	685	4,166	$530,547
2016	686	4,282	$574,944
2017	720	4,300	$561,196
2018	668	4,315	$612,788
2019	622	4,009	$579,434
2020	515	3,261	$442,986
2021	528	3,155	$379,930
2022	892	3,020	$234,150
2023	724	4,148	$250,424
2024	731	3,884	$260,720

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	245	1,193	$207,940
2016	230	1,109	$205,520
2017	233	1,134	$200,873
2018	235	1,062	$183,341
2019	212	936	$165,770
2020	196	947	$177,401
2021	230	882	$156,715
2022	320	1,003	$220,089
2023	388	1,636	$512,405
2024	336	1,215	$539,094

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	236	266	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	259	259	$61
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	235	448	$19
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	322	618	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	569	678	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	383	17,624	$339,247
Xarelto	Rivaroxaban	197	8,952	$163,525
Metoprolol Succinate	Metoprolol Succinate	244	16,133	$4,298
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	15	630	$3,369
Nadolol	Nadolol	23	1,590	$1,619

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$315	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James A. Coman, M.D.?

Tedicare shows public-source Medicare data for James A. Coman, M.D. (NPI 1417927815), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James A. Coman, M.D. have ACO affiliation data?

James A. Coman, M.D. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to James A. Coman, M.D.?

James A. Coman, M.D. is linked to PHOEBE PHYSICIAN GROUP INC (billing NPI 1487899464) in the available physician profile data.

Does James A. Coman, M.D. have Open Payments data?

James A. Coman, M.D. has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.